Efficacy and Safety of Glycaemic Control of Levemir [insulin detemir] or Insulatard [insulin suspension isophane] in Patients With Type 2 Diabetes

Trial Profile

Efficacy and Safety of Glycaemic Control of Levemir [insulin detemir] or Insulatard [insulin suspension isophane] in Patients With Type 2 Diabetes

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Nov 2016

At a glance

  • Drugs Insulin detemir (Primary) ; Insulin suspension isophane (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 Jun 2012 Additional lead trial investigator (Beril Tom-de Vries) identified as reported by ClinicalTrials.gov.
    • 16 Oct 2009 Actual patient number (342) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top